Clinical Trial Update: Recombinant Subunit Herpes Zoster Vaccine in VZV-Seronegative Organ Transplant Recipients [Phase 3]

View source ↗

Summary

Phase 3 trial update for a recombinant subunit herpes zoster vaccine in varicella zoster seronegative organ transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicella Zoster Vaccine

Snippet

Sponsor: University Health Network, Toronto | Conditions: Varicella Zoster Vaccine | Phase 3 | Status: COMPLETED